{"originalText": "，缘于入院前1月余于我院诊为肝曲结肠粘液腺癌侵犯十二指肠及肝门区，于2016-08-03在全麻上行剖腹探查+胃空肠吻合+升结肠-横结肠侧侧吻合术，，术中见:腹腔内无明显腹水，肝脏表面光滑，盆腔、肠系膜、网膜表面未见明显结节，升结肠肠管略扩张，结肠肝曲可触及一大小约8*7CM肿物，质硬，侵出浆膜层，并向后侵犯包绕十二指肠降部、水平部，向下侵犯肝十二指肠韧带上方，肿物部分与后腹膜粘连致密固定无法分离。遂行下术，术顺，术后予补液、抗感染、营养支持等治疗。，术后病理：(左结肠动脉旁淋巴结)，：送检淋巴结1个见粘液腺癌转移，结合免疫组化结果，考虑消化系统来源。，免疫组化结果：CK7（-），CK20（+++），PAX-8（-），CDX2（+++）。并于2016-08-24予“乐沙定100MGIVGTTQDD1+卡培他滨1500MGPOBID×14天”方案行第1周期化疗，辅以保胃、保护粘膜、止吐及营养支持处理。今为行上一周期化疗，就诊我院门诊，门诊拟“升结肠癌术后化疗”收住入院，病程中精神、饮食、睡眠尚可，大小便正常，体重较前上降2KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 49, "end_pos": 72}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 166}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 257}, {"end_pos": 339, "label_type": "药物", "overlap": 0, "start_pos": 336}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 354}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 425, "end_pos": 433}]}
